Company overview
USCC
91370322MA3CAX6T3R
Id2
370322200020364
English Name
Shandong Lixin Pharmaceutical Co., Ltd.
Former names
-
Chinese Name
山东立新制药有限公司
Entity type
Other Limited Liability Company
Authorized capital
¥16,000
Phone
+865337257800
Representative
曾德利
Establishment date
20 May 2016
Country
China
Primary goods traded
| Data Source | HS Code | Description | Buyer | Buyer Country | Seller | Seller Country | ||
|---|---|---|---|---|---|---|---|---|
| 7 July 2022 | IN | 29389090 | 2,3-Di-O-Acetyl-5-Deoxy-5-Fluorocytidine | Msn Laboratories Private Limited | IN | Shandong Lixin Pharmaceutical Company Limited | $345,000.00 | |
| 11 December 2024 | ID | 29335990 | Nilotinib Hydrochloride Monohydrate | PT Unijaya Pratama | ID | Shandong Lixin Pharmaceutical Company Limited | $131,560.00 | |
| 11 December 2024 | ID | 29335990 | Nilotinib Hydrochloride Monohydrate | PT Unijaya Pratama | ID | Shandong Lixin Pharmaceutical Company Limited | $131,560.00 | |
| 21 August 2023 | ID | 29335990 | Nilotinib Hydrochloride Monohydrate Baik/Baru | PT Unijaya Pratama | ID | Shandong Lixin Pharmaceutical Company Limited | CN | $49,280.00 |
| Partner | Type | Total Value | Percentage |
|---|---|---|---|
| PT Unijaya Pratama | buyer | $312,400 | 47.52% |